Although Ozempic was initially approved specifically for diabetes management, it has gained attention due to its demonstrated ability to support significant weight loss in clinical studies
Personal Journal/Records: A detailed log of your symptoms, their severity, how they impacted your daily life, and any conversations with doctors regarding the side effects
The reported results are promising: Over 80% relative bioavailability Around 160 higher bioavailability vs oral tablets Sustained drug levels for ~1 week (once-weekly dosing potential) Additionally, the microneedle patches are stable at room temperature, eliminating the need for cold storage, unlike semaglutide injections
Rapid weight loss without adequate protein and resistance training may worsen weakness, balance problems, and frailty risk
Compounded GLP-1 medications may also be available through licensed 503A pharmacies when clinically appropriate